Xiamen, China – March 23, 2026 – Shanghai STAC Biotechnology Co., Ltd., a leading provider of in vitro diagnostic (IVD) solutions, has successfully concluded its participation in the 23rd China International In Vitro Diagnostic Expo (CACLP), held from March 21 to 23, 2026, at the Xiamen International Expo Center.
As one of the world's largest and most influential IVD exhibitions, CACLP 2026 brought together over 1,200 exhibitors from more than 20 countries and regions, attracting over 100,000 professional visitors from across the global diagnostics community. The event showcased cutting-edge innovations across hematology, immunology, molecular diagnostics, POCT, and laboratory automation, reflecting the rapid evolution of the IVD industry.
A Showcase of Comprehensive Diagnostic Solutions
At Booth 2-2312, Shanghai STAC presented its extensive portfolio of IVD products, drawing significant interest from domestic and international visitors. The company's exhibition highlighted:
Hematology Analyzers & Reagents – featuring both 3-part and 5-part differential solutions
POCT Dry Fluorescence Immunoassay Analyzers – delivering rapid and accurate point-of-care testing
POCT Test Kits – covering a broad range of clinical applications
New AD (Alzheimer's Disease) POCT Diagnostic Products – marking the latest addition to STAC's innovative pipeline
"Our participation in CACLP 2026 provided an excellent platform to reconnect with existing partners and establish new connections with distributors, healthcare professionals, and industry peers from around the world," said a representative from Shanghai STAC. "The response to our product offerings-particularly our new AD POCT diagnostic solutions-has been overwhelmingly positive."
A Premier Industry Platform
CACLP 2026 featured several notable innovations, including the first-ever "Silent Hall" designed to facilitate more focused business conversations, a dedicated AI Smart Healthcare Zone, and a New Consumer Medical-Home Testing Zone that captured emerging trends in decentralized diagnostics. The event also hosted nearly 100 academic forums and business matching sessions, reinforcing its role as a vital hub for industry collaboration and knowledge exchange.
The exhibition's strong focus on internationalization, with national pavilions from Canada, Germany, and South Korea, aligned well with Shanghai STAC's commitment to expanding its global footprint.
Looking Ahead
Building on the momentum generated at CACLP 2026, Shanghai STAC Biotechnology Co., Ltd. remains dedicated to delivering high-quality, innovative diagnostic solutions that address the evolving needs of healthcare providers worldwide. The company extends its gratitude to all visitors, partners, and industry colleagues who made this exhibition a resounding success.
For more information about Shanghai STAC's products and solutions, please visit www.shanghaistac.com or contact the sales team at jhn@stacbio.com.
About Shanghai STAC Biotechnology Co., Ltd.
Shanghai STAC Biotechnology Co., Ltd. is a professional manufacturer and supplier of in vitro diagnostic products, specializing in hematology analyzers and reagents, POCT systems, and related diagnostic solutions. With a commitment to quality, innovation, and customer satisfaction, STAC serves clients across China and international markets, providing reliable diagnostic tools for laboratories and healthcare institutions.
Media Contact:
Shanghai STAC Biotechnology Co., Ltd.
Email: stac@stacbio.com
WhatsApp: +86 13817316352
Website: www.shanghaistac.com